Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Inactivation of Used Culture Broth – V 2.0

Posted on By


Biosimilars: SOP for Inactivation of Used Culture Broth – V 2.0


Standard Operating Procedure for Inactivation of Used Culture Broth in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/113/2025
Supersedes SOP/BS/113/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for safe, compliant, and effective inactivation of used culture broth from biosimilar upstream processes to prevent environmental contamination and ensure biosafety before disposal.

2. Scope

This SOP applies to all spent culture broths and residual biomass generated during biosimilar cell culture operations in seed bioreactors, production bioreactors, and media holding tanks within the upstream manufacturing facility.

3. Responsibilities

  • Production Operator: Execute broth inactivation using approved methods and document activity.
  • Utility/Engineering Team: Ensure availability of heating or chemical dosing systems.
  • QA: Review inactivation records and verify compliance.

4. Accountability

The Head of Production is accountable for ensuring all used culture broths are rendered non-infectious and disposed of as per regulatory standards.

5. Procedure

5.1 Pre-Inactivation Checks

  1. Confirm culture harvest completion and authorization for inactivation.
  2. Verify inactivation vessel is cleaned, sanitized, and calibrated.
  3. Record batch number, volume of culture broth, and vessel ID in Annexure-1.

5.2 Inactivation Methods

5.2.1 Thermal Inactivation

  1. Ensure vessel jacket or coil heating system is functional.
  2. Set target temperature: 121°C for 30 minutes.
  3. Start heating cycle and monitor via temperature gauge or SCADA system.
  4. Record start and end time of hold period and confirm temperature profile.

5.2.2 Chemical Inactivation (Alternative)

  1. Prepare 1% sodium hypochlorite or validated chemical disinfectant.
  2. Add to vessel at 10% v/v under agitation.
  3. Hold for minimum 1 hour ensuring contact with all surfaces and broth mass.
  4. Confirm pH (10–11) and perform microbial kill test if applicable.

5.3 Post-Inactivation Confirmation

  1. Record final parameters in Annexure-2.
  2. Take sample (optional) and send to QC for total viable count (TVC) testing.
  3. Label vessel or transfer line as “Inactivated” post-confirmation.

5.4 Disposal

  1. Drain inactivated broth into Effluent Treatment Plant (ETP) or through designated deactivation pit.
  2. Flush lines with WFI or potable water as per standard cleaning protocol.

6. Abbreviations

  • SCADA: Supervisory Control and Data Acquisition
  • ETP: Effluent Treatment Plant
  • TVC: Total Viable Count
  • QA: Quality Assurance

7. Documents

  1. Broth Inactivation Log – Annexure-1
  2. Inactivation Confirmation Sheet – Annexure-2

8. References

  • WHO TRS 999 – Environmental Biosafety in Biopharmaceutical Facilities
  • EPA Guidelines for Biohazardous Waste Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Broth Inactivation Log

Date Batch No. Volume (L) Method Operator Remarks
04/05/2025 BS-BT-301 200 Thermal Sunita Reddy Cycle OK

Annexure-2: Inactivation Confirmation Sheet

Parameter Set Value Achieved Hold Time Verified By
Temperature 121°C 121.4°C 30 min Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added chemical inactivation as alternate method and ETP reference Process enhancement
See also  Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Creams: SOP for Conducting Internal Quality Audits for Cream Manufacturing – V 2.0
Next Post: Gel Manufacturing: SOP for Qualification of Gel Manufacturing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version